InflaRx (IFRX) Market Capitalization (2017 - 2026)
InflaRx (IFRX) recorded Market Capitalization of $161.94 million in Q2 2026, up 245.4% from $46.89 million a year earlier and up 151.7% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Market Capitalization (2017 - 2026) Analysis & Trends
For FY2025, InflaRx reported Market Capitalization of $73.02 million, down 50.2% from FY2024.
- Annual Market Capitalization has a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- Across earlier years, Market Capitalization came in at $146.6 million in FY2024 (+52.7%), $95.98 million in FY2023 (-30.7%), $138.58 million in FY2022 (-34.1%) and $210.41 million in FY2021 (+48.2%).
- The Q2 2026 figure is the highest quarterly Market Capitalization since Q2 2023.
- On a year-over-year basis, Market Capitalization rose in three of the last eight quarters, with growth averaging 15.3%.
- Peak year-over-year performance for Market Capitalization in the last five years was growth of 245.4% in Q2 2026, against a decline of 54.2% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $64.34 million (Q1 2026), $73.02 million (Q4 2025) and $79.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | InflaRx | 104.63 Mn | -228.98 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 161.94 Mn |
| Mar 31, 2026 | 64.34 Mn |
| Dec 31, 2025 | 73.02 Mn |
| Sep 30, 2025 | 79.53 Mn |
| Jun 30, 2025 | 46.89 Mn |
| Mar 31, 2025 | 60.54 Mn |
| Dec 31, 2024 | 146.60 Mn |
| Sep 30, 2024 | 90.09 Mn |
| Jun 30, 2024 | 102.46 Mn |
| Mar 31, 2024 | 90.68 Mn |
| Dec 31, 2023 | 95.98 Mn |
| Sep 30, 2023 | 133.22 Mn |
| Jun 30, 2023 | 199.38 Mn |
| Mar 31, 2023 | 86.73 Mn |
| Dec 31, 2022 | 138.58 Mn |
| Sep 30, 2022 | 116.70 Mn |
| Jun 30, 2022 | 64.10 Mn |
| Mar 31, 2022 | 80.89 Mn |
| Dec 31, 2021 | 210.41 Mn |
| Sep 30, 2021 | 73.11 Mn |
API Access
InflaRx Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();